Guided Therapeutics (GTHP) Common Equity (2010 - 2026)
Guided Therapeutics (GTHP) posted Common Equity of -$132000.0 for Q4 2025, up 97.66% sequentially from -$5.6 million in Q3 2025, and up 97.3% YoY from -$66903.2 in Q4 2024.
Guided Therapeutics (GTHP) Common Equity (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Common Equity for 16 years, with the latest figure at -$132000.0 in Q4 2025.
- Quarterly Common Equity rose 97.3% year-over-year to -$132000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$132000.0 (up 97.3% YoY) and the FY2025 annual result came in at -$132000.0, up 97.3% from the prior year.
- Common Equity grew to -$132000.0 in Q4 2025 per GTHP's latest filing, from -$5.6 million in the prior quarter.
- Over five years, Common Equity peaked at -$132000.0 in Q4 2025 and troughed at -$8.0 million in Q1 2021.
- A 5-year average of -$4.7 million and a median of -$4.9 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2024 and 2025: Common Equity sank 40.78% in 2024, then soared 97.3% in 2025.
- Over 5 years, Common Equity stood at -$5.4 million in 2021, then surged by 47.05% to -$2.9 million in 2022, then plunged by 32.02% to -$3.8 million in 2023, then slipped by 28.46% to -$4.9 million in 2024, then jumped by 97.3% to -$132000.0 in 2025.
- According to Business Quant data, Common Equity over the past three periods registered -$132000.0, -$5.6 million, and -$5.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | -5.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.76 Mn |
| Dec 31, 2025 | -132,000.00 |
| Sep 30, 2025 | -5.65 Mn |
| Jun 30, 2025 | -5.47 Mn |
| Mar 31, 2025 | -5.03 Mn |
| Dec 31, 2024 | -4.89 Mn |
| Sep 30, 2024 | -4.92 Mn |
| Jun 30, 2024 | -4.67 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Dec 31, 2023 | -3.81 Mn |
| Sep 30, 2023 | -3.65 Mn |
| Jun 30, 2023 | -3.32 Mn |
| Mar 31, 2023 | -2.86 Mn |
| Dec 31, 2022 | -2.88 Mn |
| Sep 30, 2022 | -2.65 Mn |
| Jun 30, 2022 | -5.77 Mn |
| Mar 31, 2022 | -4.99 Mn |
| Dec 31, 2021 | -5.45 Mn |
| Sep 30, 2021 | -7.75 Mn |
| Jun 30, 2021 | -7.99 Mn |